Focused on your Heart Health
Althera announces U.S. launch of Roszet®
Althera Pharmaceuticals, a company focused on heart health, announces Roszet® (rosuvastatin and ezetimibe) tablets are now available to patients in the United States. By making this medicine available and affordable, we hope to improve long-term health of patients, including those with prior cardiovascular disease.
Please learn more about Roszet® at www.roszet.com.
Please read full Prescribing information at roszet.com/pi.
Founded in 2010, Althera develops innovative patient focused medicines to improve cardiovascular health.
Althera’s Rosuvastatin/Ezetimibe is already approved and available to patients in more than 28 countries worldwide including all major European markets.
Althera’s second product Ezetimibe/Atorvastatin tablets (AL-310), is approved in both US and Europe, and is expected to be available to patients next year.